• OPEN AN ACCOUNT
Indian Indices
Sensex
82,418.01 148.23
( 0.18%)
Global Indices
Nasdaq
48,928.31 -164.26
(-0.33%)
Dow Jones
6,963.16 -26.85
(-0.38%)
Hang Seng
53,392.10 16.50
(0.03%)
Nikkei 225
10,214.90 43.14
(0.42%)
Forex
USD-INR
91.92 0.08
(0.09%)
EUR-INR
109.97 0.03
(0.03%)
GBP-INR
126.94 0.27
(0.21%)
JPY-INR
0.60 0.00
(0.00%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
0.9167078
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
73.38
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

Dilip Buildcon wins bid for establishment of a 400/220/33 kV AIS sub-station at Mekhali
Dec 26,2025

Dilip Buildcon has been selected as the successful bidder by REC Power Development and Consultancy (RECPDCL) for “Establishing 400 kV Sub-station at Mekhali along with associated transmission lines (Belagavi District), Karnataka” for a period of 35 years from Commercial Operation Date (COD).

The project involves establishment of a 400/220/33 kV AIS sub-station at Mekhali along with associated 400 kV and 220 kV transmission lines, to be executed on Build, Own, Operate and Transfer (BOOT) basis under Tariff Based Competitive Bidding (TBCB) route.